| View |
|
DRP-9630-01
|
Ascorbic Acid + Zinc
|
Immuntab
|
500 mg (equivalent to 562.42 mg Sodium Ascorbate)/10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Am-Europharma Corporation
|
Philippines
|
-
|
24 August 2021
|
15 April 2026
|
| View |
|
DRP-9630-02
|
Ascorbic Acid + Zinc
|
Zeefence
|
500mg (equivalent to 562.42mg Sodium Ascorbate) / 10mg (equivalent to 27.5mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
AM-Europharma Corporation
|
Philippines
|
-
|
10 September 2021
|
15 April 2026
|
| View |
|
DRP-9631
|
Levocetirizine dihydrochloride
|
None
|
2.5mg/ 5mL
|
Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Initial
|
16 April 2021
|
16 April 2026
|
| View |
|
DRP-9632
|
Multivitamins + Minerals
|
DOCVATE PRONATAL
|
Each Film-coated tablet contains:
Retinyl Acetate (Vitamin A), USP-3600IU Cholecalciferol (Vitamin D3), USP-500IU d-Alpha-Tocopheryl Acetate (Vitamin E), USP-23IU Ascorbic Acid (Vitamin C), USP-100mg Niacinamide (Vitamin B3), USP-19mg Calcium Pantothenate (Vitamin B5), USP-8.45mg Pyridoxine Hydrochloride (Vitamin B6), USP-8.45mg Riboflavin-5-Phosphate Sodium (Vitamin B2), USP-1.8mg Thiamine Monohydrate (Vitamin B1), USP-1.6mg Folic Acid (Vitamin B9), USP-800mcg
Cyanocobalamin (Vitamin B12), USP-4mcg Calcium (as Calcium Carbonate and Calcium Hydrogen Phosphate Anhydrous),USP-125mg Phosphorus (as Calcium Carbonate and Calcium Hydrogen Phosphate Anhydrous), USP-125mg Magnesium (as Oxide), USP-100mg Iron (as Ferrous Fumarate), USP-60mg Zinc (as Oxide), USP-7.5mg Copper (as Sulfate Phentahydrate), USP-1mg Manganese (as Sulfate Monohydrate), USP-1mg
|
Film Coated Tablet
|
-
|
Phil. United Pharma Corporation
|
Philippines
|
Initial (OTC)
|
16 April 2021
|
16 April 2026
|
| View |
|
DRP-9633
|
Aluminum Hydroxide + Magnesium Hydroxide
|
Maalum
|
200 mg/ 200 mg
|
Chewable Tablet
|
-
|
Phil. United Pharma Corporation
|
Philippines
|
Initial (OTC)
|
21 April 2021
|
21 April 2026
|
| View |
|
DRP-9634
|
Hyoscine (as N-Butylbromide) + Paracetamol
|
Butasine Plus
|
10mg/500mg
|
Film-Coated Tablet
|
-
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
Initial (PCPR) (OTC)
|
16 April 2021
|
16 April 2026
|
| View |
|
DRP-9635
|
Sevalamer Carbonate
|
Sevrose-800
|
800 mg
|
Film Coated Tablet
|
Drug for treatment of hyperkalemia and hyperphosphatemia
|
Pharose Remedies Limited
|
India
|
Initial
|
21 April 2021
|
21 April 2026
|
| View |
|
DRP-9635-01
|
Sevelamer Carbonate
|
None
|
800mg
|
Film-coated tablet
|
-
|
Pharose Remedies Limited
|
India
|
Initial(CLIDP)
|
12 August 2021
|
21 April 2026
|
| View |
|
DRP-9635-02
|
Sevelamer Carbonate
|
SEVERQO
|
800 mg
|
Film-Coated Tablet
|
Drug for treatment of hyperkalemia and hyperphosphaternia
|
Pharose Remedies Limited
|
India
|
CLIDP Conversion
|
29 July 2022
|
21 April 2026
|
| View |
|
DRP-9636
|
Sevalamer Carbonate
|
Corvelam
|
800 mg
|
Film Coated Tablet
|
Drug for treatment of hyperkalemia and hyperphosphatemia
|
Pharose Remedies Limited
|
India
|
Initial
|
21 April 2021
|
21 April 2026
|
| View |
|
DRP-9636-01
|
Sevelamer Carbonate
|
None
|
800mg
|
Film-coated tablet
|
-
|
Pharose Remedies Limited
|
India
|
Initial(CLIDP)
|
12 August 2021
|
21 April 2026
|
| View |
|
DRP-9637
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Zopian-4.5
|
4 g/500 mg
|
Powder For IV Infusion
|
ANTIBACTERIAL (PENICILLIN/BETA-LACTAMASE INHIBITOR)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
Initial
|
28 February 2022
|
23 April 2026
|
| View |
|
DRP-9637-01
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Retazollin-4.5
|
4 g/500 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd
|
India
|
-
|
09 December 2021
|
23 April 2026
|
| View |
|
DRP-9637-02
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Tazastar-4.5
|
4 g/500 mg
|
Powder For IV Infusion
|
ANTIBACTERIAL (PENICILLIN/BETA-LACTAMASE INHIBITOR)
|
Injectcare Parenterals Pvt. Ltd
|
India
|
-
|
21 March 2022
|
23 April 2026
|
| View |
|
DRP-9637-03
|
PIPERACILLIN (AS SODIUM) + TAZOBACTAM (AS SODIUM)
|
PIPZO HOSPI
|
4 G/500 MG
|
POWDER FOR IV INFUSION
|
ANTIBACTERIAL (PENICILLIN/BETA-LACTAMASE INHIBITOR)
|
INJECTCARE PARENTERALS PVT. LTD.
|
India
|
CLIDP Conversion
|
16 August 2022
|
23 April 2026
|
| View |
|
DRP-9637-04
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Dontazo
|
4 g/500 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
-
|
06 September 2022
|
23 April 2026
|
| View |
|
DRP-9637-05
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pitazovin
|
4 g/500 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 September 2022
|
23 April 2026
|
| View |
|
DRP-9637-06
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Berazoba-4.5
|
4g/500mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 December 2022
|
23 April 2026
|
| View |
|
DRP-9637-07
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Piptazonob-4.5
|
4 g/500 mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt.Ltd.
|
India
|
CLIDP Conversion
|
07 March 2023
|
23 April 2026
|
| View |
|
DRP-9637-08
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Tazasave-4.5
|
4g/500mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
INJECTCARE PARENTERALS PVT. LTD.
|
India
|
CLIDP Conversion
|
12 November 2023
|
24 April 2026
|